| 2013 | 2014 | 2015 | |
|---|---|---|---|
| Total expenditure (triennial)(€) | 15 121 487 | ||
| % of expenditure | 28% | 31% | 41% |
| No of patients | 184 | 204 | 235 |
| Expenditure per patient(€) | 23 011 | 22 979 | 26 382 |
| Evolution of annual expenditure | |||
| Oncological disease | 19% | 27% | 31% |
| Pompe disease | 33% | 30% | 25% |
| Multiple myeloma | 24% | 21% | 31% |
| Idiopathic thrombocytopenic purpura | 5% | 3% | 3% |
| Gauche disease | 4% | 4% | 6% |
| Other | 15% | 15% | 4% |